Stay updated with breaking news from Replimune Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Replimune Group, Inc. (NASDAQ:REPL – Get Free Report) insider Pamela Esposito sold 1,400 shares of Replimune Group stock in a transaction dated Friday, August 11th. The stock was sold at an average price of $20.00, for a total value of $28,000.00. Following the sale, the insider now directly owns 263,436 shares of the company’s stock, […]
Integral Health Asset Management LLC increased its holdings in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the 1st quarter, Holdings Channel.com reports. The fund owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the period. Integral Health Asset Management LLC’s holdings in Replimune Group were […]
Integral Health Asset Management LLC lifted its stake in shares of Replimune Group, Inc. (NASDAQ:REPL – Free Report) by 79.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 395,000 shares of the company’s stock after acquiring an additional 175,000 shares during the […]
Adaptimmune Therapeutics (ADAP – Research Report) received a Sell rating and a $1.00 price target from Barclays analyst Peter Lawson yeste...
Replimune Group (NASDAQ:REPL – Free Report) had its price target reduced by HC Wainwright from $51.00 to $50.00 in a report published on Monday, MarketBeat.com reports. They currently have a buy rating on the stock. Separately, Piper Sandler reiterated an overweight rating and issued a $44.00 target price on shares of Replimune Group in a […]